A possible case of venlafaxine-induced Stevens-Johnson syndrome

Journal of Clinical Psychiatry

Volumn 65, Issue 10, 2004, Pages 1431-1433

  Weiss, Nicholas Tsvi ^a   Jones, Lee ^a   Chamberlain, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE; METHYLPREDNISOLONE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; LETTER; MAJOR DEPRESSION; RASH; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; EXANTHEMA; FEMALE; HUMANS; METHYLPREDNISOLONE; SEROTONIN UPTAKE INHIBITORS; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME;

EID: 13644252876     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n1020d     Document Type: Letter

References (18)

1. Fritsch PO, Ruiz-Maldonado R. Stevens-Johnson syndrome: toxic epidermal necrolysis. In: Freedberg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's Dermatology in General Medicine, vol 1. 5th ed. New York, NY: McGraw Hill; 1999:644-653
2. Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 2000;1:349-360
3. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002;8:5. Available at: http://dermatology.cdlib. org/DOJvol8num1/reviews/drugrxn/ ghislain.html. Accessed Aug 22, 2004
4. Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997;24:726-729 (Pubitemid 28030717)
5. Labreze CL, Lamireau T, Chawki D, et al. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000;83:347-353 (Pubitemid 30744779)
6. Warnock CA, Azadian AG. Cross-sensitivity between paroxetine and sertraline. Ann Pharmacother 2002;36:631-633 (Pubitemid 34270278)
7. Jan V, Toledano C, Machet L, et al. Stevens-Johnson syndrome after sertraline [letter]. Acta Derm Venereol 2000;42:287
8. Bodokh I, Lacour JP, Rosenthal E, et al. Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after fluoxetine [in French] [letter]. Thérapie 1992;47:411
9. Vincent A, Douville M, Baruch P. Serum sickness induced by fluoxetine [letter]. Am J Psychiatry 1991;148:1602-1603
10. Wolkenstein P, Arevuz J, Diehl JL. Toxic epidermal necrolysis after fluvoxamine [letter]. Lancet 1993;342:304-305 (Pubitemid 23224440)
11. Tripathi A, Greenburger PA. Bupropion hydrochloride induced serum sickness-like reaction. Ann Allergy Asthma Immunol 1999;83:165-166 (Pubitemid 29399082)
12. Bagshaw SM, Cload B, Gilmour J, et al. Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. Ann Allergy Asthma Immunol 2003;90:572-575 (Pubitemid 36827397)
13. Warnock JK, Knesevich JW. Adverse cutaneous reactions to antidepressants. Am J Psychiatry 1988;145:425-430 (Pubitemid 18099118)
14. Gutierrez MA, Stimmel GL, Aiso JY. Venlafaxine: a 2003 update. Clin Ther 2003;25:2138-2154
15. Beauclaire L, Radoi-Andraous D, Chouinard G. Selective serotoninnoradrenaline reuptake inhibitors. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000:2427-2432
16. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 1998;59:502-508 (Pubitemid 28492413)
17. Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol 1996;16:54S-61S (Pubitemid 126730223)
18. Sidwell RU, Swift S, Yan C-L, et al. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin. Int J Clin Pract 2003;57:643-645 (Pubitemid 37185086)